Mirtazapine
Product Images NDC 52959-902

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 52959-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel-30 mg 500 Tablets Bottle (Mirtazapine Fig5)

Package Label-principal Display Panel-30 mg 500 Tablets Bottle (Mirtazapine Fig5)
This appears to be a medication label for Mirtazapine 30mg tablets. It includes information such as lot number, manufacturer, expiration date, and dosage instructions. The medication is used to treat depression and should only be taken as directed by a doctor.*
FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.